NYSE:CVSHealthcare
Should FTC Insulin Settlement And PBM Lawsuit Shift How Investors View CVS Health’s (CVS) Risk-Reward Profile?
CVS Health recently reached a proposed settlement with the Federal Trade Commission over insulin pricing practices in its Caremark pharmacy benefit manager unit, while also facing a new class action lawsuit alleging improper formulary-related fees.
At the same time, CVS Health’s board affirmed its quarterly US$0.665 dividend and added former Elevance Health CFO John E. Gallina as an audit committee financial expert, underscoring governance and capital-return priorities amid regulatory...